Combinent Biomedical Systems

Transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders

placeLexington, Massachusetts, United States calendar_todayFounded 2000 language combinentbiomedical.com

Innovation

2 patent families — focus: Human necessities; filing pace dormant. Cited 33 times.

YearFilings
20132
20142
20151
20171

Investor mix

3 investors on record; lead investors include VIMAC Ventures, Commons Capital, Cytyc.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon